# reload+after+2024-01-21 02:46:50.594800
address1§2042 Corte Del Nogal
city§Carlsbad
state§CA
zip§92011
country§United States
phone§760 918 9165
website§https://www.qualigeninc.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
fullTimeEmployees§31
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Michael S. Poirier', 'age': 67, 'title': 'President, COO, CEO & Chairman', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 583180, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tariq  Arshad M.B.A., M.D.', 'age': 53, 'title': 'Senior VP & Chief Medical Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 400138, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christopher L. Lotz', 'age': 57, 'title': 'VP of Finance, CFO & Corporate Secretary', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 578555, 'exercisedValue': 0, 'unexercisedValue': 60608}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.079
priceToSalesTrailing12Months§0.55100435
currency§USD
dateShortInterest§1702598400
forwardEps§-1.0
exchange§NCM
quoteType§EQUITY
shortName§Qualigen Therapeutics, Inc.
longName§Qualigen Therapeutics, Inc.
firstTradeDateEpochUtc§1435066200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a1b07075-9ae7-3e85-a808-a7a339883cd9
gmtOffSetMilliseconds§-18000000
targetHighPrice§5.0
targetLowPrice§5.0
targetMeanPrice§5.0
targetMedianPrice§5.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§0.388
grossMargins§0.056900002
ebitdaMargins§0.0
trailingPegRatio§None
